LAS VEGAS -- GlaxoSmithKline will pay $90 million for unlawfully promoting Avandia, a diabetes drug linked to heart attacks.
The settlement will be split among 37 states. Nevada's share will be $1.5 million.
"These enforcement provisions are important to protect Nevadans and others across the country," said Nevada Attorney General Catherine Cortez Masto. "I am pleased to join this multi-state agreement to ensure that Nevadans are not misled by this company's deceptive marketing practices."
Wednesday kicks off American Stroke Month, and medical professionals want people to recognize the warning signs of strokes. Two doctors and stroke experts discussed the dangers on 8 News NOW This Morning.More>>